RxDoctor Payments DataLook up a doctor →

Luis Sumoza, MD

Hematology · North Miami Beach, FLNPI 1003258583

Payments from drug & device makers

$76,537in general payments, 2019–2025

Across 478 payments — averaging $160.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$36K
  • Novartis$22K
  • GSK$3K
  • Bristol Myers Squibb$3K
  • Dova Pharmaceuticals$2K
  • Johnson & Johnson$1K
  • plus $10K from 54 others

What the payments were for

  • Consulting fees$3,93025%
  • Food & beverage$11,53872%
  • Education$5734%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC1$36,138
Novartis16$22,407
GSK31$2,551
Bristol Myers Squibb16$2,533
Dova Pharmaceuticals4$1,535
Johnson & Johnson18$1,301
AstraZeneca(2 entities)36$988
Merck37$886
Pfizer24$757
Daiichi Sankyo Inc.15$483
Takeda Pharmaceuticals U.S.A., Inc.17$418
Pharmaessentia USA Corporation18$381
Incyte Corporation12$329
Sanofi15$321
Tempus AI, Inc13$309
Genentech USA, Inc.12$290
Bayer13$266
Amgen9$263
Seagen Inc.7$256
Lilly USA, LLC12$252
Coherus Oncology, Inc.8$249
Pharmacosmos Therapeutics Inc.9$199
Adaptive Biotechnologies Corporation2$175
Servier Pharmaceuticals LLC7$175
Pharmacyclics LLC, An Abbvie Company8$168
AbbVie5$149
Array Biopharma Inc6$143
EMD Serono, Inc.6$130
AVEO Pharmaceuticals, Inc.2$127
Karyopharm Therapeutics Inc.5$126
Aimmune Therapeutics, Inc.1$125
AMAG Pharmaceuticals, Inc.1$124
Regeneron Healthcare Solutions, Inc.4$99
Dendreon Pharmaceuticals LLC4$97
Rigel Pharmaceuticals, Inc.5$97
Sun Pharmaceutical Industries Inc.4$95
Ipsen Biopharmaceuticals, Inc5$91
Stemline Therapeutics Inc.4$83
Agios Pharmaceuticals, Inc.4$81
Beigene USA, Inc.4$78
Blueprint Medicines Corporation3$70
Azurity Pharmaceuticals, Inc.3$68
Taiho Oncology, Inc.3$65
Apellis Pharmaceuticals, Inc.2$62
Eisai Inc.3$62
Sobi, Inc3$60
Mirati Therapeutics, Inc.2$59
Myriad Genetic Laboratories, Inc.2$54
Octapharma USA, Inc.2$51
Gilead2$51
Deciphera Pharmaceuticals Inc.2$50
Legend Biotech USA Inc.2$49
Tersera Therapeutics LLC2$48
Astellas Pharma US Inc2$41
Springworks Therapeutics, Inc.2$40
Beone Medicines USA, Inc.2$38
ADC Therapeutics America, Inc.2$37
Puma Biotechnology, Inc.2$36
E.r. Squibb & Sons, L.L.C.2$28
Recordati_rare_diseases_inc.1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,537 in reported general payments places this provider in the 75th percentile of 79 hematology providers in Florida.

See all hematology providers in Florida

Medicare billing

Part B allowed, 2024
$6,127
Medicare patients
34
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl11$2,346
Bicalutamide12$1,030
Hydroxyurea23$341

Paid to pharmacies, not to this prescriber.

Other hematology in North Miami Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →